دابيجاتران إيتيكسيلات ميسيلات
| Kind | API |
|---|---|
| Class | Anticoagulant — direct thrombin (factor IIa) inhibitor (DOAC), prodrug |
| Synonyms | BIBR 1048, Pradaxa, dabigatran etexilate mesilate |
| Common uses / forms | Oral capsules with tartaric-acid pellet core 75 / 110 / 150 mg |
| Properties | Double-prodrug ester; very low oral bioavailability (~6.5%); hygroscopic and moisture-sensitive; needs acidic (tartaric-acid) microenvironment for absorption; polymorph control critical |
| Compendia | USP |
| Sourcing origins | India, China |
| Dominant inbound route | Hormuz |
| Indicative price band | $$$$ (> $1000 / kg) |
| Indicative lead time | medium (50–80 days) |
| Notes | Strongly hygroscopic — moisture-protective packaging and low-RH handling; capsule stability is the key formulation risk; salt/polymorph identity must match innovator |
Open the interactive Data Bank (363 substances) · the full table · Supply Resilience Studio
Share: LinkedIn · X · WhatsApp · Telegram · Email
Cite as: AUPAM Experts' Office, Dabigatran etexilate mesylate — sourcing profile (API) — AUPAM Data Bank, retrieved 2026-08-31, https://aupameo.org/datasets/databank/a-dabigatran-etexilate-mesylate.html